General MedicationsINJECTIONStandard
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
CLINDAMYCIN PHOSPHATE
Standard Dose
EQ 6MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is listed in Drugs@FDA under application 214401 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 6MG BASE/ML Sponsor HIKMA Submission history Latest submission status date: 2023-04-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is listed in Drugs@FDA under application 214401 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 6MG BASE/ML Sponsor HIKMA Submission history Latest submission status date: 2023-04-05 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.